Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-κB acetylation in human neuroblastoma cells

Journal of Neurochemistry

Volumn 101, Issue 5, 2007, Pages 1194-1204

  Li, Yinghui ^a   Zhao, Yanyan ^a   Li, Guangyu ^a   Wang, Jun ^a   Li, Tingting ^a   Li, Wei ^a   Lu, Jingyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acetylation; Gene expression; Nervous system; nNOS; Nuclear factor B; Trichostatin A

Indexed keywords

DNA; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NUCLEAR FACTOR KAPPA B SUBUNIT P50; TRANSCRIPTION FACTOR RELA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TRANSACTIVATION; UPREGULATION; WESTERN BLOTTING;

ACETYLATION; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; INDAZOLES; LUCIFERASES; NEUROBLASTOMA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 34248205235     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04407.x     Document Type: Article

References (34)

1. Ammanamanchi S., Freeman J. W. Brattain M. G. (2003) Acetylated sp3 is a transcriptional activator. J. Biol. Chem. 278, 35 775 35 780.
2. Boissel J. P., Zelenka M., Godtel-Armbrust U., Feuerstein T. J. Forstermann U. (2003) Transcription of different exons 1 of the human neuronal nitric oxide synthase is dynamically regulated in a cell- and stimulus-specific manner. Biol. Chem. 384, 351 362.
3. Bredt D. S. (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31, 577 596.
4. Bredt D. S., Hwang P. M., Glatt C. E., Lowenstein C., Reed R. R. Snyder S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714 718.
5. Bros M., Boissel J. P., Godtel-Armbrust U. Forstermann U. (2006) Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87, 463 473.
6. Camelo S., Iglesias A. H., Hwang D. et al. (2005) Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164, 10 21.
7. Chabrier P. E., Demerle-Pallardy D. Auguet M. (1999) Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell. Mol. Life Sci. 55, 1029 1035.
8. Chan C. F., Sun W. Z., Lin J. K. Lin-Shiau S. Y. (2000) Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. Eur. J. Pharmacol. 402, 61 68.
9. Chen L., Fischle W., Verdin E. Greene W. C. (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653 1657.
10. Chen L. F., Mu Y. Greene W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21, 6539 6548.
11. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. USA 88, 6368 6371.
12. Dawson T. M., Dawson V. L. Snyder S. H. (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32, 297 311.
13. Deng W. G. Wu K. K. (2003) Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J. Immunol. 171, 6581 6588.
14. Deng W. G., Zhu Y. Wu K. K. (2003) Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J. Biol. Chem. 278, 4770 4777.
15. Fish J. E., Matouk C. C., Rachlish A., Lin S., Tai S. C., D'Abreo C. Marsden P. A. (2005) The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J. Biol. Chem. 280, 24 824 24 838.
16. Gan Y., Shen Y. H., Wang J., Wang X., Utama B., Wang J. Wang X. L. (2005) Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J. Biol. Chem. 280, 16 467 16 475.
17. Hall A. V., Antoniou H., Wang Y., Cheung A. H., Arbus A. M., Olson S. L., Lu W. C., Kau C. L. Marsden P. A. (1994) Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem. 269, 33 082 33 090.
18. Huang W., Zhao S., Ammanamanchi S., Brattain M., Venkatasubbarao K. Freeman J. W. (2005) Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280, 10 047 10 054.
19. Izumi H., Ohta R., Nagatani G., Ise T., Nakayama Y., Nomoto M. Kohno K. (2003) p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene. Biochem. J. 373, 713 722.
20. Kalb R. G. Agostini J. (1993) Molecular evidence for nitric oxide-mediated motor neuron development. Neuroscience 57, 1 8.
21. Kawamura T., Ono K., Morimoto T. et al. (2005) Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J. Biol. Chem. 280, 19 682 19 688.
22. Kiernan R., Bres V., Ng R. W., Coudart M. P., EI Messaoudi S., Sardet C., Jin D. Y., Emiliani S. Benkirane M. (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278, 2758 2766.
23. Lee J. S., Galvin K. M., See R. H., Eckner R., Livingston D., Moran E. Shi Y. (1995) Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 9, 1188 1198.
24. Liu R., Gutierrez A. M., Ring A. Persson A. E. (2002) Nitric oxide induces resensitization of P2Y nucleotide receptors in cultured rat mesangial cells. J. Am. Soc. Nephrol. 13, 313 321.
25. Merlo E., Freudenthal R. Romano A. (2002) The IκB kinase inhibitor sulfasalazine impairs long-term memory in the crab Chasmagnathus. Neuroscience 112, 161 172.
26. Rouaux C., Loeffler J. P. Boutillier A. L. (2004) Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem. Pharmacol. 68, 1157 1164.
27. Saur D., Seidler B., Paehge H., Schusdziarra V. Allescher H. D. (2002) Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J. Biol. Chem. 277, 25 798 25 814.
28. Shibuki K. Okada D. (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349, 326 328.
29. Soos J., Engelhardt J. I., Siklos L., Havas L. Majtenyi K. (2004) The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease. Neuroreport 15, 1715 1718.
30. Sung S., Yang H., Uryu K., Lee E. B., Zhao L., Shineman D., Trojanowski J. Q., Lee V. M. Pratico D. (2004) Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165, 2197 2206.
31. Wang Y., Newton D. C., Robb G. B., Kau C. L., Miller T. L., Cheung A. H., Hall A. V., VanDamme S., Wilcox J. N. Marsden P. A. (1999) RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc. Natl Acad. Sci. USA 96, 12 150 12 155.
32. Yoshida M., Kijima M., Akita M. Beppu T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17 174 17 179.
33. Yu Z., Zhang W. Kone B. C. (2002) Histone deacetylases augment cytokine induction of the iNOS gene. J. Am. Soc. Nephrol. 13, 2009 2017.
34. Zhao Y. Y., Zhou J., Narayanan C. S., Cui Y. Kumar A. (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33, 108 115.